Following a comprehensive three year medical doctor administered and
evidence-based Human Clinical Studies, NeuroMedica is pleased to introduce
Nurenex, the first of a comprehensive range of new products comprising our
AlphaProgram of Age Management Therapeutics.
Neuroceutical products developed by Nathan Sassover, and now marketed globally
by NeuroMedica Inc., meet the highest standards of safety, and rapid, verifiable
effectiveness. Produced within a globally recognized world class
pharmaceutical-grade facility with over 25 years of health care supplement
experience, NeuroMedica’s Nurenex and its entire range of Age Management
Therapeutics known as the AlphaProgram is now available worldwide in recognition
of an aging population’s needs for such age intervention products in the near
term, rather than the long term timeframes usually projected by the medical
community and the media.
